

[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
[ Thu, Feb 03rd 2022
] - WOPRAI
Etzer Darout Upgraded (ALNY) to Strong Buy and Held Target at $170 on, Feb 3rd, 2022
Etzer Darout of Guggenheim, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Strong Buy and Held Target at $170 on, Feb 3rd, 2022.
Etzer has made no other calls on ALNY in the last 4 months.
There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 1 agrees with Etzer's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $109 on, Friday, January 28th, 2022
These are the ratings of the 9 analyists that currently disagree with Etzer
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $350 on, Thursday, January 20th, 2022
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $215 on, Tuesday, January 18th, 2022
- Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $205 on, Monday, November 22nd, 2021
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $273 on, Monday, November 22nd, 2021
- Luca Issi of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $225 on, Monday, November 22nd, 2021
- Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021
- Esther Rajavelu of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $215 on, Monday, October 4th, 2021
Contributing Sources